• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “abraxane” Archives

          in
          Entry Author Date Location
          AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results Ben Fidler 04/03/19 National
          The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski Ben Fidler 03/11/19 National
          Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy Ben Fidler 12/02/16 Boston
          Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out Ben Fidler 08/08/16 Boston
          West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More Alex Lash 06/26/15 San Diego
          East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More Ben Fidler 08/25/14 Boston
          Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 Ben Fidler 05/01/14 Boston
          Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO Ben Fidler 03/10/14 Boston
          East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More Ben Fidler 01/10/14 Boston
          East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More Ben Fidler 09/13/13 Boston
          Investors to Get $300M as FDA Approves Celgene Drug For Pancreatic Cancer Ben Fidler 09/06/13 New York
          Cerulean Pharma Arrives at Turning Point With Cancer Drug Luke Timmerman 03/06/13 Boston
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Xcelerating Life Sciences Philadelphia: Special Report

            From Our Editors · Special Report

            Xcelerating Life Sciences Philadelphia: Special Report

            Becoming the Cell & Gene Therapy Hub

          • What to Include in Your Life Sciences Company Fundraising Pitch Deck

            Sponsored · Whitepaper

            What to Include in Your Life Sciences Company Fundraising Pitch Deck

            What the most successful life sciences fundraising pitch decks all have in common

            Brex
          • The Bay Area and Beyond: Biocom Talks Innovation and COVID

            Sponsored · Video

            The Bay Area and Beyond: Biocom Talks Innovation and COVID

            A Fireside Chat with Biocom President & CEO Joe Panetta

            Biocom

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.